Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:04:18.201Z.
Calculation as of: 2026-10-06T16:04:18.201Z.
Quote observation: 2026-10-06T15:59:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a446221ee70341de49d615c46e15f9be625c30a72cedc9ff9e6473dbc59ae23
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
NRx Pharmaceuticals, Inc.
Market Cap
$124.91M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$122.93M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$121.63M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.83M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$131.16M
Free Cash Flow Yield
9.96%
TTM Avg
8.24%
3Y Avg
8.24%
5Y Avg
8.24%
Market Cap
$117.29M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.02M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $124.91M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $122.93M | N/A | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $122.89M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.63M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $128.40M | N/A | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 9.96% | 8.24% | 8.24% | 8.24% |
| Coya Therapeutics, Inc. (COYA)vs › | $117.29M | N/A | N/A | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | N/A | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $116.59M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
